Annual Revenue
$204.00 K
+$13.00 K+6.81%
31 December 2023
Summary:
CG Oncology Common stock annual revenue is currently $204.00 thousand, with the most recent change of +$13.00 thousand (+6.81%) on 31 December 2023. CGON annual revenue is now -98.03% below its all-time high of $10.36 million, reached on 01 December 2021.CGON Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$43.00 K
-$68.00 K-61.26%
30 September 2024
Summary:
CG Oncology Common stock quarterly revenue is currently $43.00 thousand, with the most recent change of -$68.00 thousand (-61.26%) on 30 September 2024. Over the past year, it has increased by +$34.00 thousand (+377.78%). CGON quarterly revenue is now -91.87% below its all-time high of $529.00 thousand, reached on 31 March 2024.CGON Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$684.00 K
+$34.00 K+5.23%
30 September 2024
Summary:
CG Oncology Common stock TTM revenue is currently $684.00 thousand, with the most recent change of +$34.00 thousand (+5.23%) on 30 September 2024. Over the past year, it has increased by +$481.00 thousand (+236.95%). CGON TTM revenue is now at all-time high.CGON TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CGON Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.8% | +377.8% | +236.9% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
CGON Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -98.0% | +6.8% | -91.9% | +4200.0% | at high | +252.6% |
| 5 y | 5 years | -98.0% | +6.8% | -91.9% | +4200.0% | at high | +252.6% |
| alltime | all time | -98.0% | +6.8% | -91.9% | +4200.0% | at high | +252.6% |
CG Oncology Common Stock Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $43.00 K(-61.3%) | $684.00 K(+5.2%) |
| June 2024 | - | $111.00 K(-79.0%) | $650.00 K(+20.6%) |
| Mar 2024 | - | $529.00 K(>+9900.0%) | $539.00 K(+164.2%) |
| Dec 2023 | $204.00 K | $1000.00(-88.9%) | $204.00 K(+0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $9000.00(-95.4%) | $203.00 K(+4.6%) |
| Mar 2023 | - | $194.00 K | $194.00 K |
| Dec 2022 | $191.00 K(-98.2%) | - | - |
| Dec 2021 | $10.36 M | - | - |
FAQ
- What is CG Oncology Common stock annual revenue?
- What is the all time high annual revenue for CG Oncology Common stock?
- What is CG Oncology Common stock annual revenue year-on-year change?
- What is CG Oncology Common stock quarterly revenue?
- What is the all time high quarterly revenue for CG Oncology Common stock?
- What is CG Oncology Common stock quarterly revenue year-on-year change?
- What is CG Oncology Common stock TTM revenue?
- What is the all time high TTM revenue for CG Oncology Common stock?
- What is CG Oncology Common stock TTM revenue year-on-year change?
What is CG Oncology Common stock annual revenue?
The current annual revenue of CGON is $204.00 K
What is the all time high annual revenue for CG Oncology Common stock?
CG Oncology Common stock all-time high annual revenue is $10.36 M
What is CG Oncology Common stock annual revenue year-on-year change?
Over the past year, CGON annual revenue has changed by +$13.00 K (+6.81%)
What is CG Oncology Common stock quarterly revenue?
The current quarterly revenue of CGON is $43.00 K
What is the all time high quarterly revenue for CG Oncology Common stock?
CG Oncology Common stock all-time high quarterly revenue is $529.00 K
What is CG Oncology Common stock quarterly revenue year-on-year change?
Over the past year, CGON quarterly revenue has changed by +$34.00 K (+377.78%)
What is CG Oncology Common stock TTM revenue?
The current TTM revenue of CGON is $684.00 K
What is the all time high TTM revenue for CG Oncology Common stock?
CG Oncology Common stock all-time high TTM revenue is $684.00 K
What is CG Oncology Common stock TTM revenue year-on-year change?
Over the past year, CGON TTM revenue has changed by +$481.00 K (+236.95%)